The introduction of teprotumumab for the treatment of thyroid eye disease has dramatically improved management of this life-changing condition; however, clinical trials and experience in the clinic have revealed associated hearing abnormalities.
- Jason A. Brant
- Don O. Kikkawa
- Terry J. Smith